🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

11,276 results for “Te” Clear

  1. Xolair

    United Therapeutics Europe Ltd

    Atopic Eczema

    approved small molecule completed

    1 trial

  2. Xolair 150 mg solution for injection in pre-filled syringe, Physiological saline

    Disc Medicine

    Carotid artery stenosis

    approved small molecule active

    1 trial

  3. Xtandi - 40 mg soft capsules

    The George Institute

    PROSTATE CANCER

    approved small molecule active

    1 trial

  4. Xyrem (X)

    Jazz Pharmaceuticals Ireland Limited

    Obstructive Sleep Apnea Syndrome

    approved small molecule completed

    1 trial

  5. Z-Brace interbody fusion device

    Hospital Authority, Hong Kong

    Cervical Disc Degeneration

    approved other active

    1 trial

  6. ZYNRELEF 200Mg-6Mg Extended-Release Solution

    Heron Therapeutics

    Post Operative Pain, Acute

    approved small molecule active

    1 trial

  7. Zaredrop 75 mg/ml soluzione orale, Laroxyl 40 mg/ml gocce orali soluzione, FLUOXETINA DOC Generici 20 mg/5 ml Soluzione orale, Zoloft 20 mg/ml concentrato per soluzione orale, Brintellix 20 mg/ml oral drops, solution, Daparox 33,1 mg/ml, gocce orali, soluzione., CITALOPRAM ABC 40 mg/ml gocce orali, soluzione, ESCITALOPRAM DOC 20 mg/ml gocce orali, soluzione

    Verona Pharma Ireland Limited

    Patients with currently remitted depressive disorders.

    approved small molecule active

    1 trial

  8. Zeposia 0.92 mg hard capsules

    Verona Pharma Ireland Limited

    Relapsing Multiple Sclerosis (relapsing-remitting, relapsing-progressive)

    approved small molecule active

    1 trial

  9. Ziagen 300 mg film-coated tablets, INTELENCE 200 mg tablets, Eviplera 200 mg/25 mg/245 mg film-coated tablets, EDURANT 25 mg film-coated tablets, Telzir 700 mg film-coated tablets, TRIZIVIR 300 mg/150 mg/300 mg film-coated tablets, Delstrigo 100 mg/300 mg/245 mg film-coated tablets, Norvir 100 mg film-coated tablets, Ritonavir Accord 100 mg filmomhulde tabletten, Descovy 200 mg/10 mg film-coated tablets, REYATAZ 300 mg hard capsules, REKAMBYS 600 mg prolonged-release suspension for injection, Tivicay 50 mg

    Disc Medicine

    HIV-infected

    approved small molecule active

    1 trial

  10. Zithromax

    United Therapeutics Europe Ltd

    Asthma

    approved small molecule completed

    1 trial

  11. Zoledronate

    United Therapeutics Europe Ltd

    Hip Fractures

    approved small molecule active

    1 trial

  12. Zushima plaster with high dose

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Osteoarthritis

    approved small molecule completed

    1 trial

  13. [68Ga]FAPI-46

    Disc Medicine

    post-acute sequelae of COVID-19

    approved small molecule active

    1 trial

  14. [68Ga]FAPI-46

    Disc Medicine

    Peyronie's Disease

    approved small molecule active

    1 trial

  15. aflibercept 2.0 mg

    Regeneron UK Limited

    Diabetic Macular Edema

    approved small molecule completed

    1 trial

  16. aflibercept 2.0 mg

    Regeneron UK Limited

    Age Related Macular Degeneration

    approved small molecule completed

    1 trial

  17. alglucosidase alfa

    Sanofi Pasteur

    Pompe Disease (Infantile-Onset)

    approved mab terminated

    1 trial

  18. alglucosidase alfa

    Sanofi Pasteur

    Pompe Disease

    approved mab completed

    1 trial

  19. allopurinol

    United Therapeutics Europe Ltd

    Gout

    approved small molecule completed

    1 trial

  20. alogliptin+pioglitazone

    Takeda

    Diabetes Mellitus, Type 2

    approved small molecule terminated

    1 trial

  21. aripiprazole

    Otsuka Beijing Research Institute

    Bipolar Disorder

    approved small molecule completed

    1 trial

  22. armodafinil

    Teva Pharma GmbH

    Sleep Disorders

    approved small molecule completed

    1 trial

  23. artemether lumefantrine

    United Therapeutics Europe Ltd

    Uncomplicated Malaria

    approved small molecule completed

    1 trial

  24. artemether-lumefantrine (ALN)

    United Therapeutics Europe Ltd

    Uncomplicated Malaria

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources